Jacqueline Keller

Chief Business Officer at Neurochase - the premier next generation platform for drug delivery to the brain #CED

[Jacqueline Keller @canuck1973]

Innovation thrives when neurosurgeons and biomedical engineers unite. Thank you @ONdrugDelivery for featuring @Neurochase's next gen CED platform for direct brain delivery designed to be efficient, effective & highly-scalable 🧠🧬#Nsgy #geneandcelltherapy #CED #intraparenchymal

[Neurochase - Next Generation CNS Delivery @neurochase]

Our fantastic partnership with Fearsome featured in the latest edition of @ONdrugDelivery shares the development story behind our novel & highly-scalable platform for gene and cell therapy delivery. 🧬 #neurochase #fearsome #cell #gene #intraparenchymal
https://t.co/TzEi32cyXv

[Neurochase - Next Generation CNS Delivery @neurochase]

Wonderful feature sharing how Neurochase is transforming direct brain CED from the floor of #ASGCT2026 today. Many thanks to The Biotech Voyageur for stopping by our booth!
https://t.co/THyFTP3IEP
#neurosurgery #genetherapy @biotechvoyager

[Neurochase - Next Generation CNS Delivery @neurochase]

CED is evolving. Are you?🧠Join Neurochase at #ASGCT2026 (Booth #971) to see the nFuse™ System in action. Our 2-hour target-to-end, multi-infusion CED procedure is designed for existing robots & frames in the OR today.

📍 Poster 3478 📅 May 14, 5PM #GeneTherapy #Neurotwitter

[Jacqueline Keller @canuck1973]

Big news! Please join me in welcoming Dr. Max Woolley & Julia Williams to @neurochase 📢

Their clinical-trial leadership arrives at a pivotal stage as we expand partnerships & accelerate life-changing solutions with next-gen CED #NeuroTwitter #BTSM #genetherapy #celltherapy

[Neurochase - Next Generation CNS Delivery @neurochase]

Thrilled to welcome Dr. Max Woolley & Julia Williams to @Neurochase! Joining from Renishaw following our neuroinfuse™ acquisition, their expertise in drug delivery & R&D arrives as we prepare for clinical trials later this year. Welcome to the team! 🚀#NeuroTech #ClinicalTrials

[Jacqueline Keller @canuck1973]

Incredible news for CNS drug delivery! @Neurochase has acquired Renishaw Neuro Solutions' assets, including the Neuroinfuse™ system.

This proven technology enables chronic delivery of life-changing therapies for conditions like #Parkinsons Disease & childhood cancer #DIPG.

[Neurochase - Next Generation CNS Delivery @neurochase]

Neurochase acquires Neuroinfuse™ drug delivery system & IP from Renishaw Neuro Solutions! 🧠 This advanced, chronic delivery system significantly boosts our portfolio for the £1.5B CNS market. Clinical trial planned for early 2026. https://t.co/kirsjqRs2e

#CNS #DIPG #CED #NSGY

[Jacqueline Keller @canuck1973]

Anyone who knows me (men & women) know how passionately I support HRT -- not just for longevity, but for ensuring peri- and post-menopausal women maintain quality of life. The unnecessary suffering caused by the estrogen black box (& progesterone, & testosterone) is staggering.

[60 Minutes @60Minutes]

“It's very hard not to argue that this is the greatest single failure of the modern medical system,” says Dr. Peter Attia, referring to the hesitancy to prescribe hormone replacement therapy for perimenopausal and menopausal women. https://t.co/g7LbhIrY5f

[Jacqueline Keller @canuck1973]

Really looking forward to meeting our current and prospective cell and gene partners next week to share our next-gen CED drug delivery platform designed to be workflow agnostic, and globally scalable. 🧠🌎🌵
#CGMesa25
#CED
#Neurosurgery
#GeneTherapy
@neurochase

[Neurochase - Next Generation CNS Delivery @neurochase]

Our Chief Marketing Officer @canuck1973 will be in Phoenix next week to attend the @alliancerm Cell & Gene Therapy Meeting on the Mesa. Connect with Jacquie to find out more about our effective, efficient and scalable medical device for targeted delivery to the CNS.

[Jacqueline Keller @canuck1973]

Looking forward to sharing exciting data demonstrating the unique capabilities of our @neurochase next generation drug delivery platform for Convection Enhanced Delivery tomorrow at the @UCSD 2nd Annual Gene Therapy Initiative Symposium. #GeneTherapy #CED #Neurosurgery #Nsgy

[Neurochase - Next Generation CNS Delivery @neurochase]

Meet @canuck1973 tomorrow at the 2nd Annual Gene Therapy Initiative Symposium hosted by @UCSanDiego at the @SalkInstitute in La Jolla, where we'll present a poster on the @neurochase acute drug delivery system. Details in link: https://t.co/UZ9y0DAXjR

[Jacqueline Keller @canuck1973]

@Neurochase is expanding our software team! This Jr. Software Engineer position offers an opportunity to gain experience in gene therapy delivery to the brain, working alongside some of the greatest minds in the field. #UKjobs #Hiring #medicalsoftware

https://t.co/Ho7XJWKuIB

[Neurochase - Next Generation CNS Delivery @neurochase]

Neurochase is expanding! This is an excellent opportunity for a Neuroscience BSc graduate in the UK to work closely with some of the world’s experts in intraparenchymal drug delivery. #UKTalent #NeuroscienceJobs #BiotechCareers #preclinical
Check it out! https://t.co/HMQzKcVLcJ

[Jacqueline Keller @canuck1973]

Neurochase’s fantastic R&D partner Fearsome is hiring a Quality Engineer to support a variety of projects, including drug delivery and combination products. If you’re interested in joining a super smart, creative, and hard-working team, check it out! 👀
https://t.co/6Q8qugQgJ0

[Neurochase - Next Generation CNS Delivery @neurochase]

Our founder Professor Steven Gill will deliver an oral presentation at @ASGCTherapy annual conference tomorrow morning at 9.30 local time in the New Orleans Theatre. Don't miss it. You can also still visit us @ booth 1057. #ASGCT2025

[Gene Therapy Institute at Ohio State University @OSUGeneTherapy]

Fantastic presentation by Brad Elder, MD on “Convection Enhanced Delivery of #genetherapy Surgical Workflow” 🧬 #asgct2025 @NeurosurgeryOSU

[Neurochase - Next Generation CNS Delivery @neurochase]

What a fantastic response to our abstract poster presentation at @ASGCTherapy annual meeting last night. Oral presentation from our founder Prof. Steven Gill to come this Saturday at 8am in New Orleans Theater. Visit our booth 1057 this week for more. #ASGCT2025 #CED

[Neurochase - Next Generation CNS Delivery @neurochase]

#ASGCT2025 just kicked off, stop by booth 1057 to learn how our next generation CNS delivery platform is designed to be the most efficient, effective, and scalable system available for pre-clinical and clinical trials.
#CED #genetherapy #celltherapy #neurosurgery

[Neurochase - Next Generation CNS Delivery @neurochase]

We will be at the @ASGCTherapy annual meeting next week to showcase our game-changing CED medical device, host an abstract poster and deliver an oral presentation. Visit booth 1057 to find out more about our pioneering work in drug delivery to the CNS. Details below.

[Jacqueline Keller @canuck1973]

I'll be at #ASGCT2025 next week in New Orleans as a 1st time exhibitor with members of the @neurochase leadership team. Join us at our booth (1057), attend our abstract presentations below, or sign up for a product demo here: https://t.co/fhQXMjbUcG
#ASGCT2025 #CED #GeneTherapy

[Jacqueline Keller @canuck1973]

Looking forward to meeting our @Neurochase current & prospective pharma partners using #intraparenchymal delivery with #CED for #GeneTherapy & #CellTherapy to treat neurodegenerative & oncologic diseases in the brain. Please join us at booth #1057 to learn more #ASGCT2025 #Nsgy

[Neurochase - Next Generation CNS Delivery @neurochase]

Meet our team at #ASGCT2025 next month to learn how our next generation CNS Delivery Platform for gene and cell therapy is efficient, effective, and truly scalable.
https://t.co/WRGuGakvxM

#ASGCT2025 #CED #genetherapy #celltherapy #intraparenchymal #neurosurgery #neurochase

[Jacqueline Keller @canuck1973]

Such a warm welcome from the @neurochase team! We can impact millions suffering from neurological disorders with what I believe is THE revolutionary next gen #CED drug delivery platform designed to be not only fast and accurate, but also highly scalable.
https://t.co/ijB8YB85uk

[Jacqueline Keller @canuck1973]

Excited to announce my new role as Chief Marketing Officer @neurochase ! Can't wait to drive the commercialization of their innovative technology, set to revolutionize gene and cell delivery to the brain.
https://t.co/9z1RHSE8IO
#CED #Nsgy #GeneTherapy #Neurochase #celltherapy